Cargando…

Topical Corticosteroid-Resolved Rubeosis Iridis with Neovascular Glaucoma Caused by Noninfectious Granulomatous Uveitis

PURPOSE: We report a case of topical corticosteroid treatment-resolved rubeosis iridis with neovascular glaucoma (NVG) caused by noninfectious granulomatous uveitis. CASE REPORT: A 61-year-old woman with left ocular pain and blurred vision was referred to our department. Visual acuity and intraocula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sora, Daisuke, Takayama, Kei, Taguchi, Manzo, Sato, Tomohito, Sakurai, Yutaka, Kanda, Takayuki, Takeuchi, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903156/ https://www.ncbi.nlm.nih.gov/pubmed/29681844 http://dx.doi.org/10.1159/000488137

Ejemplares similares

Rubeosis iridis
por: Pagoulatos, Dionysios, et al.
Publicado: (2017)

Visible Blood Flow in a Case of Rubeosis Iridis
por: Tanito, Masaki, et al.
Publicado: (2021)

Rubeosis Iridis Resulting from Agenesis of the Internal Carotid Artery: A Case Report
por: Gyotoku, Yuuji, et al.
Publicado: (2008)

UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis
por: Locri, Filippo, et al.
Publicado: (2019)

Tozinameran: Panuveitis, iridis rubeosis re-activation and cystoid macular oedema: case report
Publicado: (2022)

Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy
por: Locri, Filippo, et al.
Publicado: (2020)

Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study
por: Jeong, Yun Cheol, et al.
Publicado: (2016)

Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report
por: Taguchi, Manzo, et al.
Publicado: (2017)

Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies
por: Sato, Tomohito, et al.
Publicado: (2018)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Age-related differences in the clinical features of ocular sarcoidosis
por: Takayama, Kei, et al.
Publicado: (2018)

Severe panuveitis with iridis rubeosis activation and cystoid macular edema after BioNTech-Pfizer COVID-19 vaccination in a 17-year-old
por: Achiron, Asaf, et al.
Publicado: (2022)

Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
por: Yasuda, Mami, et al.
Publicado: (2017)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis
por: Goldstein, Debra A., et al.
Publicado: (2016)

Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study
por: Takeuchi, Masaru, et al.
Publicado: (2019)

Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018)

Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021)

Practice patterns regarding regional corticosteroid treatment in noninfectious Uveitis: a survey study
por: McHarg, Matthew, et al.
Publicado: (2022)

Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy
por: Karti, Omer, et al.
Publicado: (2020)

Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013)

Targeting interleukin-6 for noninfectious uveitis
por: Lin, Phoebe
Publicado: (2015)

Noninfectious Manifestations and Complications of Chronic Granulomatous Disease
por: Henrickson, Sarah E, et al.
Publicado: (2018)

Case of Colloboma Iridis
por: Garwood, A.
Publicado: (1850)

Clinical Outcomes of Cyclosporine Treatment for Noninfectious Uveitis
por: Lee, Sun Ho, et al.
Publicado: (2012)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)

Noninfectious Uveitis in Rheumatology: Patterns, Treatment, and Outcomes
por: Younus, Raheel, et al.
Publicado: (2023)

Lenticular opacities in vitiligo iridis
por: Kumar, Deepa A, et al.
Publicado: (2020)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
por: Palla, Swetha, et al.
Publicado: (2015)

Noninfectious uveitis: strategies to optimize treatment compliance and adherence
por: Dolz-Marco, Rosa, et al.
Publicado: (2015)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
por: Roesel, Martin, et al.
Publicado: (2011)

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
por: Pasadhika, Sirichai, et al.
Publicado: (2014)

Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
por: Maya, Jose R., et al.
Publicado: (2014)

A review and update on orphan drugs for the treatment of noninfectious uveitis
por: You, Caiyun, et al.
Publicado: (2017)

Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review
por: Norcia, Luiz Fernando, et al.
Publicado: (2021)

Case Report: A Promising Treatment Strategy for Noninfectious Uveitis
por: Liu, Xiao-Bao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8cdn2650ut0slbrf9u3cd5vl8